Hemangioblast: origin of hemangioblastoma in von Hippel-Lindau (VHL) syndrome

von-Hippel Lindau (VHL) hereditary cancer syndrome

Inactivating germline von Hippel–Lindau (VHL) mutations

| The von Hippel–Lindau disease is caused by inactivating germline mutations of the VHL tumour suppressor gene and is associated with an increased risk of a variety of tumours in an allele-specific manner. The role of the heterodimeric transcription factor hypoxia-inducible factor (HIF) in the pathogenesis of VHL-defective tumours has been more firmly established during the past 5 years. In add...

[von Hippel-Lindau syndrome].

LABORATORY DATA adrenal changes phaeochromocytoma adrenal cortex hormones adrenal insufficiency, adrenal hypoplasia aldosterone, high levels chromosomal assignment chromosome 11q localization chromosome 3p localization gene, structural-functional anomalies CCND1 (PRAD1) cyclin D1, gene chr.11q13 gene analysis-DNA analysis ST11 (PETS1), gene chr.3p25 VHL von Hippel-Lindau syndrome, gene chr.3p26...

Von Hippel-Lindau Syndrome.

Von Hippel-Lindau (VHL) disease is a hereditary cancer syndrome characterized by the development of multiple vascular tumours. The syndrome is caused by inactivation of the VHL protein (pVHL) and increased production of VEGF, PDGF, and TGF-α. The course of VHL syndrome is associated with the development of multiple vascular tumours. Most frequently, these include retinal and central nervous sys...

Germline mutations in the Von Hippel-Lindau (VHL) gene

Introduction Von Hippel-Lindau (VHL) disease is a complex, autosomal, dominant inherited disorder, variably presenting with retinal and cerebellar haemangioblastoma, renal cell carcinoma, phaeochromocytoma and endolymphatic sac tumours. Cysts and cystadenoma may develop in kidney, pancreas and epididymis. Germline mutations in the VHL tumour suppressor gene are found in most of the families ful...